Keep up-to-date with the latest access to medicines news and research, plus interviews and opinion from our partners and other experts, and videos and photo stories of our work.
News - Page 4 of 28
-
The pandemic is declared finished, but the fight for access never stops
MMA consortium members from Argentina, Brazil, Thailand and EECA region, took action to secure access to molnupiravir. In Argentina, the...
-
Being ahead of the curve: access to Delamanid in Thailand
MMA’s consortium partner, the Thai Network of People Living with HIV/AIDS (TNP+), has filed a third-party observation on a patent...
-
Civil Society Organizations in Brazil fight for better access to Dolutegravir
Brazilian Interdisciplinary AIDS Association (ABIA), along with the Working Group on Intellectual Property (GTPI) of the Brazilian Network for the...
-
Paxlovid in the post pandemic world
The World Health Organization (WHO) recently declared that COVID-19 is “…now an established and ongoing health issue which no longer...
-
Hurdles and opportunities for Hepatitis C treatment in Thailand
Kularb Dangtong is the leader of a comprehensive HIV continuum of care center (CCC Center) in Thailand. CCC Centers are...
-
Patent-free, low-cost vaccines highly protective against severe COVID
A new analysis of 390,459 participants assessing 14 different COVID-19 vaccines has identified no significant difference in efficacy against both symptomatic and severe...
-
TNP+ opposes patent claims on Lenacapavir
TNP+, MMA’s partner in Thailand, has filled an opposition against Markush patent claims on lenacapavir, a new, long-acting antiretroviral drug,...
-
In times of peace and in times of war: 100% LIFE outstanding work in Ukraine
After two years of the worst pandemic in recent history, 2022 marked an extra tragic event in the history of...
-
GSIPA2M – Day 2
Welcome to Day 2 of GISPA2M 2022! Plenary III – Big Pharma’s multiverse of Madness Andrew Hill, University of Liverpool,...
-
GSIPA2M – Day 1
Welcome to the first day of 2022 GSIPA2M – The Pandemic Edition: Reclaiming Access Sergiy Kondratyuk, ITPC Global, Ukraine Sergiy...
-
GSIPA2M 2022 – The Pandemic Edition: Reclaiming Access
Civil Society from across the globe will gather in Istanbul from the 19th to the 21st of July 2022 for...
-
Activists Across the World Demand Urgent Action to Improve Access to Lifesaving Tuberculosis (TB) Medicine, Bedaquiline
July 1, 2022 – A new generic version of bedaquiline produced by Macleods Pharmaceuticals in India has cleared the Global...
